Bosh sahifaADVM • NASDAQ
add
Adverum Biotechnologies Inc
3,43 $
Seans yopilganidan keyin:(0,00%)0,00
3,43 $
Yopilgan:14-apr, 16:02:19 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
3,43 $
Kunlik diapazon
3,26 $ - 3,59 $
Yillik diapazon
3,07 $ - 12,02 $
Bozor kapitalizatsiyasi
71,35 mln USD
Oʻrtacha hajm
154,72 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,00 mln | — |
Joriy xarajat | 9,78 mln | -29,06% |
Sof foyda | -27,13 mln | 17,49% |
Sof foyda marjasi | -2,71 ming | — |
Har bir ulushga tushum | -1,30 | 60,61% |
EBITDA | -28,33 mln | 14,20% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 153,24 mln | 30,88% |
Jami aktivlari | 234,38 mln | 19,11% |
Jami passivlari | 90,26 mln | -4,04% |
Umumiy kapital | 144,12 mln | — |
Tarqatilgan aksiyalar | 20,80 mln | — |
Narxi/balansdagi bahosi | 0,49 | — |
Aktivlardan daromad | -29,93% | — |
Kapitaldan daromad | -31,81% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -27,13 mln | 17,49% |
Operatsiyalardan naqd pul | -21,12 mln | 11,66% |
Sarmoyadan naqd pul | -13,35 mln | -173,34% |
Moliyadan naqd pul | 0,00 | 100,00% |
Naqd pulning sof oʻzgarishi | -34,47 mln | -492,17% |
Boʻsh pul | -11,77 mln | 36,71% |
Haqida
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Tashkil etilgan
1-yan, 2006
Sayt
Xodimlar soni
121
